Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers

Condition:   Oral Mucositis
Interventions:   Drug: RRx-001;   Drug: Cisplatin for injection;   Radiation: Radiation Therapy
Sponsors:   EpicentRx, Inc.;   Drais Pharmaceuticals, Inc.
Not yet recruiting

https://ift.tt/2JLKlji